Santa Ana, CA -- (ReleaseWire) -- 12/01/2016 --BioLargo, Inc. (OTCQB:BLGO) announced that its subsidiary BioLargo Maritime Solutions, Inc. has developed and created Advanced Oxidation System technology (AOS), a low energy, low cost and high performance clean-water treatment solution.

BioLargo has engaged CB&I to support implementation of proprietary technology and provide independent performance verification.

Dennis P. Calvert, BioLargo President & CEO, commented, "Our AOS, 'Advanced Oxidation System' is the low energy, low cost and high performance clean-water treatment solution. It has been shown to achieve unprecedented levels of disinfection and efficient soluble organic contaminant removal.

It has an important contribution to make to a number of industries, including the maritime industry. The AOS and all of our technical solutions deserve the attention of world-class leaders like CB&I. As opportunities materialize into formal work orders, we look forward to sharing additional details about the working relationship."

About BioLargo, Inc.
BioLargo, Inc. (BLGO) makes life better by delivering sustainable technology-based products that help solve some of the most widespread problems threatening the world's supply of water, food, agriculture, healthcare and energy. More information can be found about the company and its subsidiaries at www.BioLargo.com. Its subsidiary BioLargo Water, Inc. (www.BioLargoWater.com) showcases the Advanced Oxidation Systems, including its AOS Filter - a product in development specifically designed to eliminate common, troublesome, and dangerous (toxic) contaminants in water in a fraction of the time and cost of current technologies. It is the winner of the Technology Star award by New Technology Magazine for its breakthrough innovation for the oil industry and is named the Technology Innovation Leader in the water treatment market by Frost & Sullivan. BioLargo also owns a 50% interest in the Isan System, which was honored with a "Top 50 Water Company for the 21st Century" award by the Artemis Project now being commercialized under a license to Clarion Water, Inc. BioLargo's subsidiary Odor-No-More Inc., features award-winning products serving the pet, equine, military supply and consumer markets, including the Nature's Best Solution® and Deodorall® brands (www.OdorNoMore.com). BioLargo's subsidiary Clyra Medical Technologies, Inc. (www.ClyraMedical.com) focuses on advanced wound care management.

Safe Harbor Statement
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo's current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo's Annual Report on Form 10-K.

Contact:
Company Contact
Dennis Calvert
President and CEO
BioLargo, Inc.
949-643-9540 x2

Source: UPTICK Newswire